New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis Source: Eur Respir J 2005; 25: 715-717 Year: 2005
Effect of inhaled human insulin (EXUBERA®; EXU) vs subcutaneous insulin (SC) on lung lining fluid constituents in adults with type 1 diabetes mellitus (T1DM) Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007
Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2) Source: Annual Congress 2010 - COPD: management Year: 2010
Impaired glucose tolerance in obstructive sleep apnoea (OSA) patients – Results of oral glucose tolerance test (OGTT) Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
The relationship between lung function and blood glucose control in type 2 diabetic patients Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008
Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003
Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD) Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012
Glucose tolerance, beta-cell function and insulin sensitivity in cystic fibrosis patients awaiting lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 780s Year: 2006
Influence of the glycaemic control [HbA1c] on sleep disorders reported by 261 obese type 2 diabetic patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Pulmonary function of inhaled human insulin (Exubera®) in patients with type 2 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 742s Year: 2006
Metabolic syndrome and diabetes mellitus in COPD Source: Eur Respir Mon 2013; 59: 117-134 Year: 2013
Pulmonary function of inhaled human insulin (Exubera®) in patients with type 1 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Metabolic syndrome, fasting glucose and arterial stiffness in patients with COPD: The CIROCO study Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010
Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
Cystic fibrosis related diabetes (CFRD) and diabetic control as a determinant of pulmonary function: fact or fiction? Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008
Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005
Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012